Bidirectional screening and treatment outcomes of diabetes mellitus patients in hospitals with measures to integrate care of DM and TB and those without integration measures in Malawi

There are efforts in low and middle-income countries (LMICs) to integrate Tuberculosis (TB) and Diabetes mellitus (DM) healthcare services, as encouraged by WHO and other international health organizations. However, evidence on actual effect of different integration measures on bidirectional screeni...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BMC infectious diseases 2022-01, Vol.22 (1)
Hauptverfasser: Nyirenda, John L. Z, Wagner, Dirk, Ngwira, Bagrey, Lange, Berit
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 1
container_start_page
container_title BMC infectious diseases
container_volume 22
creator Nyirenda, John L. Z
Wagner, Dirk
Ngwira, Bagrey
Lange, Berit
description There are efforts in low and middle-income countries (LMICs) to integrate Tuberculosis (TB) and Diabetes mellitus (DM) healthcare services, as encouraged by WHO and other international health organizations. However, evidence on actual effect of different integration measures on bidirectional screening coverages and or treatment outcomes for both diseases in LMICs is scarce. Retrospective chart review analysis was conducted to determine effects of integrated care on bidirectional screening and treatment outcomes for both TB patients and people with DM (PWD) recruited in eight Malawian hospitals. Data of [greater than or equai to] 15 years old patients registered between 2016 to August 2019 were collected and analysed. 557 PWDs (mean age 54) and 987 TB patients (mean age 41) were recruited. 64/557 (11.5%) PWDs and 105/987 (10.6%) of TB patients were from an integrating hospital. 36/64 (56.3%) PWDs were screened for TB in integrated healthcare as compared to 5/493 (1.0%) in non-integrated care; Risk Difference (RD) 55.2%, (95%CI 43.0, 67.4), P < 0.001, while 10/105 (9.5%) TB patients were screened for DM in integrated healthcare as compared to 43/882 (4.9%) in non-integrated care; RD 4.6%, (95%CI - 1.1, 10.4), P = 0.065. Of the PWDs screened, 5/41 (12.2%) were diagnosed with TB, while 5/53 (9.4%) TB patients were diagnosed with DM. On TB treatment outcomes, 71/508 (14.8%) were lost to follow up in non-integrated care and none in integrated care were lost to follow-up; RD - 14.0%, (95%CI: - 17.0,-11.0), p < 0.001. Among PWDs, 40/493 (8.1%) in non-integrated care and 2/64 (3.1%) were lost to follow up in integrated care; RD - 5.0%, (95%CI:-10.0, - 0.0); P = 0.046. After [greater than or equai to] 2 years of follow up, 62.5% PWDs in integrated and 41.8% PWDs in non-integrated care were retained in care, RD 20.7, (95%CI: 8.1, 33.4), P = 0.001. We found higher bidirectional screening coverage and less loss to follow-up in one centre that made more efforts to implement integrated measures for TB and DM care than in 7 others that did not make these efforts. Decisions on local programs to integrate TB/DM care should be taken considering currently rather weak evidence and barriers faced in the local context as well as existing guidelines.
doi_str_mv 10.1186/s12879-021-07017-3
format Article
fullrecord <record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_infotracmisc_A693694253</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A693694253</galeid><sourcerecordid>A693694253</sourcerecordid><originalsourceid>FETCH-LOGICAL-g1353-4259f53b914ab5a7945d4d42d2a4b80173f7d4d99a04adaf7d35747c853b71173</originalsourceid><addsrcrecordid>eNqNkMtOwzAQRSMEEqXwA6wssWKREsdOHS_b8qrUqhIUttUkmaRGeVSxq_Jn_B5Di6CVWCAvPI9z77XseZc86HEe928sD2Ol_SDkfqACrnxx5HW4VNwPhZDHe_Wpd2btW0BMHOqO9zE0mWkxdaapoWQ2bRFrUxcM6oy5FsFVWDvWrF3aVGhZk7PMQIKO6grL0ri1ZStwhijLTM2WjV0ZB6VlG-OWxIBdtwS7hrYOixYcshRa_LK6nW5z5sNdHGlxK6O4H5oe9utCAVMoYWPOvZOcQvDi--56L_d389GjP5k9jEeDiV9wEQlfhpHOI5FoLiGJQGkZZTKTYRaCTGL6BJErGmgNgYQMqBGRkiqNSaM4rbve1c63gBIXps4b10JaGZsuBn0t-poSBFG9Pyg6GVYmbWrMDc0PBNcHAmIcvrsC1tYuxs9P_2dnr_vsJ6RmotU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Bidirectional screening and treatment outcomes of diabetes mellitus patients in hospitals with measures to integrate care of DM and TB and those without integration measures in Malawi</title><source>Springer Nature - Complete Springer Journals</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>PubMed Central Open Access</source><source>Springer Nature OA Free Journals</source><creator>Nyirenda, John L. Z ; Wagner, Dirk ; Ngwira, Bagrey ; Lange, Berit</creator><creatorcontrib>Nyirenda, John L. Z ; Wagner, Dirk ; Ngwira, Bagrey ; Lange, Berit</creatorcontrib><description>There are efforts in low and middle-income countries (LMICs) to integrate Tuberculosis (TB) and Diabetes mellitus (DM) healthcare services, as encouraged by WHO and other international health organizations. However, evidence on actual effect of different integration measures on bidirectional screening coverages and or treatment outcomes for both diseases in LMICs is scarce. Retrospective chart review analysis was conducted to determine effects of integrated care on bidirectional screening and treatment outcomes for both TB patients and people with DM (PWD) recruited in eight Malawian hospitals. Data of [greater than or equai to] 15 years old patients registered between 2016 to August 2019 were collected and analysed. 557 PWDs (mean age 54) and 987 TB patients (mean age 41) were recruited. 64/557 (11.5%) PWDs and 105/987 (10.6%) of TB patients were from an integrating hospital. 36/64 (56.3%) PWDs were screened for TB in integrated healthcare as compared to 5/493 (1.0%) in non-integrated care; Risk Difference (RD) 55.2%, (95%CI 43.0, 67.4), P &lt; 0.001, while 10/105 (9.5%) TB patients were screened for DM in integrated healthcare as compared to 43/882 (4.9%) in non-integrated care; RD 4.6%, (95%CI - 1.1, 10.4), P = 0.065. Of the PWDs screened, 5/41 (12.2%) were diagnosed with TB, while 5/53 (9.4%) TB patients were diagnosed with DM. On TB treatment outcomes, 71/508 (14.8%) were lost to follow up in non-integrated care and none in integrated care were lost to follow-up; RD - 14.0%, (95%CI: - 17.0,-11.0), p &lt; 0.001. Among PWDs, 40/493 (8.1%) in non-integrated care and 2/64 (3.1%) were lost to follow up in integrated care; RD - 5.0%, (95%CI:-10.0, - 0.0); P = 0.046. After [greater than or equai to] 2 years of follow up, 62.5% PWDs in integrated and 41.8% PWDs in non-integrated care were retained in care, RD 20.7, (95%CI: 8.1, 33.4), P = 0.001. We found higher bidirectional screening coverage and less loss to follow-up in one centre that made more efforts to implement integrated measures for TB and DM care than in 7 others that did not make these efforts. Decisions on local programs to integrate TB/DM care should be taken considering currently rather weak evidence and barriers faced in the local context as well as existing guidelines.</description><identifier>ISSN: 1471-2334</identifier><identifier>EISSN: 1471-2334</identifier><identifier>DOI: 10.1186/s12879-021-07017-3</identifier><language>eng</language><publisher>BioMed Central Ltd</publisher><subject>Complications and side effects ; Diabetes ; Diabetes therapy ; Diagnosis ; Medical screening ; Patient outcomes ; Risk factors ; Tuberculosis</subject><ispartof>BMC infectious diseases, 2022-01, Vol.22 (1)</ispartof><rights>COPYRIGHT 2022 BioMed Central Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,860,27903,27904</link.rule.ids></links><search><creatorcontrib>Nyirenda, John L. Z</creatorcontrib><creatorcontrib>Wagner, Dirk</creatorcontrib><creatorcontrib>Ngwira, Bagrey</creatorcontrib><creatorcontrib>Lange, Berit</creatorcontrib><title>Bidirectional screening and treatment outcomes of diabetes mellitus patients in hospitals with measures to integrate care of DM and TB and those without integration measures in Malawi</title><title>BMC infectious diseases</title><description>There are efforts in low and middle-income countries (LMICs) to integrate Tuberculosis (TB) and Diabetes mellitus (DM) healthcare services, as encouraged by WHO and other international health organizations. However, evidence on actual effect of different integration measures on bidirectional screening coverages and or treatment outcomes for both diseases in LMICs is scarce. Retrospective chart review analysis was conducted to determine effects of integrated care on bidirectional screening and treatment outcomes for both TB patients and people with DM (PWD) recruited in eight Malawian hospitals. Data of [greater than or equai to] 15 years old patients registered between 2016 to August 2019 were collected and analysed. 557 PWDs (mean age 54) and 987 TB patients (mean age 41) were recruited. 64/557 (11.5%) PWDs and 105/987 (10.6%) of TB patients were from an integrating hospital. 36/64 (56.3%) PWDs were screened for TB in integrated healthcare as compared to 5/493 (1.0%) in non-integrated care; Risk Difference (RD) 55.2%, (95%CI 43.0, 67.4), P &lt; 0.001, while 10/105 (9.5%) TB patients were screened for DM in integrated healthcare as compared to 43/882 (4.9%) in non-integrated care; RD 4.6%, (95%CI - 1.1, 10.4), P = 0.065. Of the PWDs screened, 5/41 (12.2%) were diagnosed with TB, while 5/53 (9.4%) TB patients were diagnosed with DM. On TB treatment outcomes, 71/508 (14.8%) were lost to follow up in non-integrated care and none in integrated care were lost to follow-up; RD - 14.0%, (95%CI: - 17.0,-11.0), p &lt; 0.001. Among PWDs, 40/493 (8.1%) in non-integrated care and 2/64 (3.1%) were lost to follow up in integrated care; RD - 5.0%, (95%CI:-10.0, - 0.0); P = 0.046. After [greater than or equai to] 2 years of follow up, 62.5% PWDs in integrated and 41.8% PWDs in non-integrated care were retained in care, RD 20.7, (95%CI: 8.1, 33.4), P = 0.001. We found higher bidirectional screening coverage and less loss to follow-up in one centre that made more efforts to implement integrated measures for TB and DM care than in 7 others that did not make these efforts. Decisions on local programs to integrate TB/DM care should be taken considering currently rather weak evidence and barriers faced in the local context as well as existing guidelines.</description><subject>Complications and side effects</subject><subject>Diabetes</subject><subject>Diabetes therapy</subject><subject>Diagnosis</subject><subject>Medical screening</subject><subject>Patient outcomes</subject><subject>Risk factors</subject><subject>Tuberculosis</subject><issn>1471-2334</issn><issn>1471-2334</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNqNkMtOwzAQRSMEEqXwA6wssWKREsdOHS_b8qrUqhIUttUkmaRGeVSxq_Jn_B5Di6CVWCAvPI9z77XseZc86HEe928sD2Ol_SDkfqACrnxx5HW4VNwPhZDHe_Wpd2btW0BMHOqO9zE0mWkxdaapoWQ2bRFrUxcM6oy5FsFVWDvWrF3aVGhZk7PMQIKO6grL0ri1ZStwhijLTM2WjV0ZB6VlG-OWxIBdtwS7hrYOixYcshRa_LK6nW5z5sNdHGlxK6O4H5oe9utCAVMoYWPOvZOcQvDi--56L_d389GjP5k9jEeDiV9wEQlfhpHOI5FoLiGJQGkZZTKTYRaCTGL6BJErGmgNgYQMqBGRkiqNSaM4rbve1c63gBIXps4b10JaGZsuBn0t-poSBFG9Pyg6GVYmbWrMDc0PBNcHAmIcvrsC1tYuxs9P_2dnr_vsJ6RmotU</recordid><startdate>20220104</startdate><enddate>20220104</enddate><creator>Nyirenda, John L. Z</creator><creator>Wagner, Dirk</creator><creator>Ngwira, Bagrey</creator><creator>Lange, Berit</creator><general>BioMed Central Ltd</general><scope>IOV</scope><scope>ISR</scope></search><sort><creationdate>20220104</creationdate><title>Bidirectional screening and treatment outcomes of diabetes mellitus patients in hospitals with measures to integrate care of DM and TB and those without integration measures in Malawi</title><author>Nyirenda, John L. Z ; Wagner, Dirk ; Ngwira, Bagrey ; Lange, Berit</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g1353-4259f53b914ab5a7945d4d42d2a4b80173f7d4d99a04adaf7d35747c853b71173</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Complications and side effects</topic><topic>Diabetes</topic><topic>Diabetes therapy</topic><topic>Diagnosis</topic><topic>Medical screening</topic><topic>Patient outcomes</topic><topic>Risk factors</topic><topic>Tuberculosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nyirenda, John L. Z</creatorcontrib><creatorcontrib>Wagner, Dirk</creatorcontrib><creatorcontrib>Ngwira, Bagrey</creatorcontrib><creatorcontrib>Lange, Berit</creatorcontrib><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><jtitle>BMC infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nyirenda, John L. Z</au><au>Wagner, Dirk</au><au>Ngwira, Bagrey</au><au>Lange, Berit</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Bidirectional screening and treatment outcomes of diabetes mellitus patients in hospitals with measures to integrate care of DM and TB and those without integration measures in Malawi</atitle><jtitle>BMC infectious diseases</jtitle><date>2022-01-04</date><risdate>2022</risdate><volume>22</volume><issue>1</issue><issn>1471-2334</issn><eissn>1471-2334</eissn><abstract>There are efforts in low and middle-income countries (LMICs) to integrate Tuberculosis (TB) and Diabetes mellitus (DM) healthcare services, as encouraged by WHO and other international health organizations. However, evidence on actual effect of different integration measures on bidirectional screening coverages and or treatment outcomes for both diseases in LMICs is scarce. Retrospective chart review analysis was conducted to determine effects of integrated care on bidirectional screening and treatment outcomes for both TB patients and people with DM (PWD) recruited in eight Malawian hospitals. Data of [greater than or equai to] 15 years old patients registered between 2016 to August 2019 were collected and analysed. 557 PWDs (mean age 54) and 987 TB patients (mean age 41) were recruited. 64/557 (11.5%) PWDs and 105/987 (10.6%) of TB patients were from an integrating hospital. 36/64 (56.3%) PWDs were screened for TB in integrated healthcare as compared to 5/493 (1.0%) in non-integrated care; Risk Difference (RD) 55.2%, (95%CI 43.0, 67.4), P &lt; 0.001, while 10/105 (9.5%) TB patients were screened for DM in integrated healthcare as compared to 43/882 (4.9%) in non-integrated care; RD 4.6%, (95%CI - 1.1, 10.4), P = 0.065. Of the PWDs screened, 5/41 (12.2%) were diagnosed with TB, while 5/53 (9.4%) TB patients were diagnosed with DM. On TB treatment outcomes, 71/508 (14.8%) were lost to follow up in non-integrated care and none in integrated care were lost to follow-up; RD - 14.0%, (95%CI: - 17.0,-11.0), p &lt; 0.001. Among PWDs, 40/493 (8.1%) in non-integrated care and 2/64 (3.1%) were lost to follow up in integrated care; RD - 5.0%, (95%CI:-10.0, - 0.0); P = 0.046. After [greater than or equai to] 2 years of follow up, 62.5% PWDs in integrated and 41.8% PWDs in non-integrated care were retained in care, RD 20.7, (95%CI: 8.1, 33.4), P = 0.001. We found higher bidirectional screening coverage and less loss to follow-up in one centre that made more efforts to implement integrated measures for TB and DM care than in 7 others that did not make these efforts. Decisions on local programs to integrate TB/DM care should be taken considering currently rather weak evidence and barriers faced in the local context as well as existing guidelines.</abstract><pub>BioMed Central Ltd</pub><doi>10.1186/s12879-021-07017-3</doi></addata></record>
fulltext fulltext
identifier ISSN: 1471-2334
ispartof BMC infectious diseases, 2022-01, Vol.22 (1)
issn 1471-2334
1471-2334
language eng
recordid cdi_gale_infotracmisc_A693694253
source Springer Nature - Complete Springer Journals; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; PubMed Central Open Access; Springer Nature OA Free Journals
subjects Complications and side effects
Diabetes
Diabetes therapy
Diagnosis
Medical screening
Patient outcomes
Risk factors
Tuberculosis
title Bidirectional screening and treatment outcomes of diabetes mellitus patients in hospitals with measures to integrate care of DM and TB and those without integration measures in Malawi
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T04%3A09%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Bidirectional%20screening%20and%20treatment%20outcomes%20of%20diabetes%20mellitus%20patients%20in%20hospitals%20with%20measures%20to%20integrate%20care%20of%20DM%20and%20TB%20and%20those%20without%20integration%20measures%20in%20Malawi&rft.jtitle=BMC%20infectious%20diseases&rft.au=Nyirenda,%20John%20L.%20Z&rft.date=2022-01-04&rft.volume=22&rft.issue=1&rft.issn=1471-2334&rft.eissn=1471-2334&rft_id=info:doi/10.1186/s12879-021-07017-3&rft_dat=%3Cgale%3EA693694253%3C/gale%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A693694253&rfr_iscdi=true